Who owns X4 Pharmaceuticals Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in X4 Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of X4 Pharmaceuticals stock

Who bought or sold X4 Pharmaceuticals Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Bain Capital Life Sciences Investors 2.1M $18M 29% Mar 2021
Ikarian Capital 1.2M $11M 50% Mar 2021
BlackRock 1.1M $9.4M 6% Mar 2021
Sio Capital Management 805k $6.9M 100% Mar 2021
Driehaus Capital Management 795k $6.8M 100% Mar 2021
Vanguard Group 737k $6.4M 0% Mar 2021
Monashee Investment Management 575k $4.9M 100% Mar 2021
Axa 569k $4.9M 0% Mar 2021
New Leaf Venture Partners 335k $2.9M 0% Mar 2021
Polaris Venture Management Co. V 312k $2.7M 0% Mar 2021
SV Life Sciences Advisers 312k $2.7M 0% Mar 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of X4 Pharmaceuticals?

Boothbay Fund Management 309k $2.7M 253% Mar 2021
State Street Corporation 277k $2.4M -32% Mar 2021
Geode Capital Management 258k $2.2M 1% Mar 2021
Abingworth 230k $2.0M 100% Mar 2021
FMR 213k $1.8M 0% Mar 2021
Northern Trust 180k $1.6M -13% Mar 2021
Hudson Bay Capital Management 172k $1.4M 100% Mar 2021
Renaissance Technologies 156k $1.3M -4% Mar 2021
Goldman Sachs Group 83k $715k 48% Mar 2021
Nuveen Asset Management 80k $689k -5% Mar 2021
Affinity Asset Advisors 75k $646k 100% Mar 2021
DAFNA Capital Management 70k $602k 100% Mar 2021
Bank of New York Mellon 54k $468k 4% Mar 2021
Dimensional Fund Advisors 47k $407k 100% Mar 2021
Jpmorgan Chase & Co 46k $396k 18% Mar 2021
Charles Schwab Investment Management 42k $359k 0% Mar 2021
Bleichroeder 36k $308k 0% Mar 2021
CalPERS 33k $280k 0% Mar 2021
Bank of America Corporation 32k $273k 61% Mar 2021
Ensign Peak Advisors 29k $246k -5% Mar 2021
California State Teachers Retirement System 25k $213k 5% Mar 2021
Barclays 21k $183k 64% Mar 2021
Rhumbline Advisers 21k $178k -4% Mar 2021
PanAgora Asset Management 14k $121k -79% Mar 2021
Manufacturers Life Insurance Company 11k $91k 100% Mar 2021
Deutsche Bank Aktiengesellschaft 10k $90k -9% Mar 2021
Pnc Financial Services 10k $89k 0% Mar 2021
American International 9.4k $81k 0% Mar 2021
New York State Common Retirement Fund 6.9k $59k 0% Mar 2021
Russell Investments 6.8k $58k 0% Mar 2021
Bnp Paribas Arbitrage, Snc 5.6k $48k 81% Mar 2021
Wells Fargo & Company 5.6k $49k -79% Mar 2021
UBS Group 4.0k $34k -74% Mar 2021
Tower Research Capital 3.0k $26k -51% Mar 2021
Royal Bank of Canada 1.7k $15k 97% Mar 2021
Legal & General Group 1.4k $12k 0% Mar 2021
Citigroup 1.1k $9.0k -65% Mar 2021
Summit Investment Advisors 987.00 $8.0k 0% Mar 2021
Bank Of Montreal 477.00 $5.0k -81% Mar 2021
Advisor Group Holdings 400.00 $3.0k 100% Mar 2021
Glassman Wealth Services 300.00 $3.0k 20% Mar 2021
Hartland & Co 100.00 $1.0k 100% Mar 2021

Who sold out of X4 Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Zacks Investment Management Dec 2020 54k $347k
ClariVest Asset Management Dec 2020 45k $289k
Minot Wealth Management Dec 2020 24k $151k
Morgan Stanley Dec 2020 22k $143k
Capital Asset Advisory Services Dec 2020 540.00 $3.0k